23.82
price up icon3.30%   0.76
after-market アフターアワーズ: 25.01 1.19 +5.00%
loading
前日終値:
$23.06
開ける:
$23.03
24時間の取引高:
218.56K
Relative Volume:
1.07
時価総額:
$640.10M
収益:
-
当期純損益:
$-69.47M
株価収益率:
-4.2556
EPS:
-5.5973
ネットキャッシュフロー:
$-73.92M
1週間 パフォーマンス:
+28.48%
1か月 パフォーマンス:
+0.97%
6か月 パフォーマンス:
-9.50%
1年 パフォーマンス:
+34.58%
1日の値動き範囲:
Value
$23.01
$24.59
1週間の範囲:
Value
$18.13
$24.59
52週間の値動き範囲:
Value
$14.42
$38.93

Lenz Therapeutics Inc Stock (LENZ) Company Profile

Name
名前
Lenz Therapeutics Inc
Name
セクター
Healthcare (1151)
Name
電話
858-925-7000
Name
住所
201 LOMAS SANTA FE DRIVE, SUITE 300, SOLANA BEACH
Name
職員
42
Name
Twitter
Name
次回の収益日
Name
最新のSEC提出書
Name
LENZ's Discussions on Twitter

LENZ を他の銘柄と比較する

株式 価格 時価総額 収益 当期純利益 現金流量 EPS
Biotechnology icon
LENZ
Lenz Therapeutics Inc
23.82 640.10M 0 -69.47M -73.92M -5.5973
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
489.10 127.47B 11.02B -535.60M -978.00M -2.20
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
563.16 62.43B 14.20B 4.41B 3.54B 38.28
Biotechnology icon
ARGX
Argen X Se Adr
596.20 37.03B 2.19B 833.04M -1.28B 12.71
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
234.56 31.06B 2.25B -278.16M -42.59M -2.17
Biotechnology icon
ONC
Beigene Ltd Adr
230.98 26.16B 3.81B -644.79M -669.77M -6.24

Lenz Therapeutics Inc Stock (LENZ) Upgrades & Downgrades

日付 アクション アナリスト 評価の変更
2025-04-14 再開されました Piper Sandler Overweight
2025-03-18 開始されました TD Cowen Buy
2024-09-27 開始されました Raymond James Outperform
2024-08-12 開始されました H.C. Wainwright Buy
2024-04-15 開始されました Leerink Partners Outperform
2024-04-15 開始されました William Blair Outperform
2024-04-10 開始されました Citigroup Buy
2024-03-27 開始されました Piper Sandler Overweight
2023-02-23 ダウングレード BofA Securities Neutral → Underperform
2023-02-23 ダウングレード Cantor Fitzgerald Overweight → Neutral
2023-02-23 ダウングレード Cowen Outperform → Market Perform
2023-01-25 ダウングレード BTIG Research Buy → Neutral
2023-01-18 ダウングレード BofA Securities Buy → Neutral
2023-01-06 ダウングレード BMO Capital Markets Outperform → Market Perform
2023-01-06 ダウングレード SVB Leerink Outperform → Mkt Perform
2022-09-15 開始されました Cantor Fitzgerald Overweight
2022-06-17 開始されました BMO Capital Markets Outperform
2022-04-14 開始されました BTIG Research Buy
2022-03-22 ダウングレード Morgan Stanley Overweight → Equal-Weight
2022-02-18 開始されました RBC Capital Mkts Sector Perform
2021-07-20 開始されました Morgan Stanley Overweight
2021-07-20 開始されました SVB Leerink Outperform
すべてを表示

Lenz Therapeutics Inc (LENZ) 最新ニュース

pulisher
09:03 AM

Before Buying LENZ Therapeutics Inc (NASDAQ: LENZ) Stock, Read This First - stocksregister.com

09:03 AM
pulisher
Apr 15, 2025

LENZ Therapeutics (NASDAQ:LENZ) Now Covered by Analysts at Piper Sandler - Defense World

Apr 15, 2025
pulisher
Apr 14, 2025

Form 424B3 LENZ Therapeutics, Inc. - StreetInsider

Apr 14, 2025
pulisher
Apr 14, 2025

Piper Sandler raises LENZ Therapeutics stock to Overweight - Investing.com Australia

Apr 14, 2025
pulisher
Apr 14, 2025

Piper Sandler raises LENZ Therapeutics stock to Overweight By Investing.com - Investing.com Canada

Apr 14, 2025
pulisher
Apr 14, 2025

Piper Sandler Projects Strong Growth for Lenz Therapeutics (LENZ) with LNZ100 | ABBV Stock News - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

Lenz Therapeutics assumed with an Overweight at Piper Sandler - TipRanks

Apr 14, 2025
pulisher
Apr 14, 2025

Wellington Management Group LLP Has $815,000 Stock Holdings in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Apr 14, 2025
pulisher
Apr 14, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by Vanguard Group Inc. - Defense World

Apr 14, 2025
pulisher
Apr 13, 2025

KLP Kapitalforvaltning AS Makes New $46,000 Investment in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Apr 13, 2025
pulisher
Apr 12, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Given Average Rating of “Buy” by Brokerages - Defense World

Apr 12, 2025
pulisher
Apr 11, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Bought by American Century Companies Inc. - Defense World

Apr 11, 2025
pulisher
Apr 11, 2025

8,485 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Bought by Raymond James Financial Inc. - Defense World

Apr 11, 2025
pulisher
Apr 07, 2025

LENZ Therapeutics: Freedom From Reading Glasses (NASDAQ:LENZ) - Seeking Alpha

Apr 07, 2025
pulisher
Apr 04, 2025

Presbyopia Treatment Market Size in 7MM is expected to grow at - openPR.com

Apr 04, 2025
pulisher
Mar 31, 2025

18,900 Shares in LENZ Therapeutics, Inc. (NASDAQ:LENZ) Purchased by Swiss National Bank - Defense World

Mar 31, 2025
pulisher
Mar 31, 2025

Swiss National Bank Takes $546,000 Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - MarketBeat

Mar 31, 2025
pulisher
Mar 27, 2025

LENZ Therapeutics Stock Is Attractive Before PDUFA (NASDAQ:LENZ) - Seeking Alpha

Mar 27, 2025
pulisher
Mar 27, 2025

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Shares Purchased by Charles Schwab Investment Management Inc. - Defense World

Mar 27, 2025
pulisher
Mar 26, 2025

Bank of New York Mellon Corp Lowers Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 26, 2025
pulisher
Mar 24, 2025

Brokers Issue Forecasts for LENZ Q2 Earnings - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

What is Leerink Partnrs’ Forecast for LENZ Q1 Earnings? - Defense World

Mar 24, 2025
pulisher
Mar 24, 2025

William Blair Issues Negative Outlook for LENZ Earnings - Defense World

Mar 24, 2025
pulisher
Mar 23, 2025

LENZ Therapeutics (NASDAQ:LENZ) Price Target Raised to $47.00 - Defense World

Mar 23, 2025
pulisher
Mar 22, 2025

Equities Analysts Offer Predictions for LENZ FY2026 Earnings - Defense World

Mar 22, 2025
pulisher
Mar 22, 2025

What is HC Wainwright’s Estimate for LENZ Q1 Earnings? - Defense World

Mar 22, 2025
pulisher
Mar 21, 2025

Lenz Therapeutics’ Earnings Call Highlights Positive Outlook - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Promising Outlook for LENZ Therapeutics: Buy Rating Affirmed Amid Strong Market Position and Upcoming Product Launch - TipRanks

Mar 21, 2025
pulisher
Mar 21, 2025

Brokerages Set LENZ Therapeutics, Inc. (NASDAQ:LENZ) PT at $35.40 - Defense World

Mar 21, 2025
pulisher
Mar 20, 2025

Citi raises LENZ Therapeutics price target to $47, keeps Buy rating - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

LENZ Therapeutics stock holds $38 target on FDA approval optimism By Investing.com - Investing.com Australia

Mar 20, 2025
pulisher
Mar 20, 2025

LENZ Therapeutics stock holds $38 target on FDA approval optimism - Investing.com

Mar 20, 2025
pulisher
Mar 20, 2025

Citi ups PT on LENZ Therapeutics on eye-drop approval confidence - TradingView

Mar 20, 2025
pulisher
Mar 19, 2025

Lenz Therapeutics outlines Q4 2025 launch plans for LNZ100 amid FDA review progress - MSN

Mar 19, 2025
pulisher
Mar 19, 2025

Earnings call transcript: LENZ Therapeutics Q4 2024 shows innovation drive - Investing.com India

Mar 19, 2025
pulisher
Mar 19, 2025

Earnings call transcript: LENZ Therapeutics Q4 2024 shows innovation drive By Investing.com - Investing.com UK

Mar 19, 2025
pulisher
Mar 19, 2025

LENZ Therapeutics, Inc. SEC 10-K Report - TradingView

Mar 19, 2025
pulisher
Mar 19, 2025

LENZ THERAPEUTICS Earnings Results: $LENZ Reports Quarterly Earnings - Nasdaq

Mar 19, 2025
pulisher
Mar 19, 2025

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights - The Manila Times

Mar 19, 2025
pulisher
Mar 19, 2025

LENZ Therapeutics Reports Fourth Quarter and Full Year 2024 Financial Results and Recent ... - The Bakersfield Californian

Mar 19, 2025
pulisher
Mar 19, 2025

LENZ Therapeutics (NASDAQ:LENZ) Now Covered by TD Cowen - Defense World

Mar 19, 2025
pulisher
Mar 18, 2025

TD Cowen lifts LENZ Therapeutics stock to buy, sets $60 target - Investing.com Canada

Mar 18, 2025
pulisher
Mar 18, 2025

TD Cowen lifts LENZ Therapeutics stock to buy, sets $60 target By Investing.com - Investing.com South Africa

Mar 18, 2025
pulisher
Mar 18, 2025

TD Cowen Initiates LENZ Therapeutics at Buy With $60 Price Target -March 18, 2025 at 07:09 am EDT - Marketscreener.com

Mar 18, 2025
pulisher
Mar 18, 2025

American Electric Power, Block and Lenz Therapeutics - TradingView

Mar 18, 2025
pulisher
Mar 17, 2025

LENZ THERAPEUTICS Earnings Preview: Recent $LENZ Insider Trading, Hedge Fund Activity, and More - Nasdaq

Mar 17, 2025
pulisher
Mar 11, 2025

LENZ Therapeutics to Report Fourth Quarter and Full Year 2024 Financial Results and Recent Corporate Highlights on March 19, 2025 - The Manila Times

Mar 11, 2025
pulisher
Mar 11, 2025

LENZ Therapeutics Q4 Earnings: Key Updates Coming on Presbyopia Eye Drops - StockTitan

Mar 11, 2025
pulisher
Mar 09, 2025

Rhumbline Advisers Boosts Stock Position in LENZ Therapeutics, Inc. (NASDAQ:LENZ) - Defense World

Mar 09, 2025

Lenz Therapeutics Inc (LENZ) 財務データ

収益

loading

当期純利益

loading

現金流量

loading

EPS

loading
$20.04
price up icon 2.51%
$72.65
price up icon 3.49%
$32.60
price up icon 1.27%
$24.61
price up icon 6.77%
$98.76
price up icon 0.52%
biotechnology ONC
$230.98
price up icon 1.24%
大文字化:     |  ボリューム (24 時間):